The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Beta Tubulin (TUBB) - Drugs in Development, 2021
US$ 3,000.00
Beta Tubulin (TUBB) - Drugs in Development, 2021 SUMMARY Beta Tubulin (TUBB) - Drugs in Development, 2021 provides in depth analysis on Beta Tubulin (TUBB) targeted pipeline therapeutics. The report p...
April 2021
30 pages
Biliary Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Biliary Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Biliary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Biliary Tumor pipeline landscape. The report provides co...
April 2021
45 pages
Blepharospasm (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Blepharospasm (Ophthalmology) - Drugs in Development, 2021 SUMMARY Blepharospasm (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Blepharospasm pipeline landscape. The report p...
April 2021
30 pages
Bone Sarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Bone Sarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Bone Sarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Bone Sarcoma pipeline landscape. The report provides compr...
April 2021
35 pages
Brain Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Brain Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Brain Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Cancer pipeline landscape. The report provides compr...
April 2021
90 pages
Brain Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Brain Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Brain Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Tumor pipeline landscape. The report provides comprehe...
April 2021
75 pages
Brenner Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Brenner Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Brenner Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Brenner Tumor pipeline landscape. The report provides co...
April 2021
30 pages
Burkitt Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Burkitt Lymphoma pipeline landscape. The report pr...
April 2021
110 pages
Cachexia (Musculoskeletal) - Drugs in Development, 2021
US$ 2,000.00
Cachexia (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Cachexia (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Cachexia pipeline landscape. The report provides com...
April 2021
50 pages
Calcium Sensing Receptor - Drugs in Development, 2021
US$ 3,000.00
Calcium Sensing Receptor - Drugs in Development, 2021 SUMMARY Calcium Sensing Receptor - Drugs in Development, 2021 provides in depth analysis on Calcium Sensing Receptor targeted pipeline therapeutic...
April 2021
35 pages
Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021
US$ 3,000.00
Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 SUMMARY Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 provides in depth analysis on Carcinoembryonic Antigen (CEA) targeted pi...
April 2021
30 pages
Carcinoid Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Carcinoid Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Carcinoid Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Carcinoid Tumor pipeline landscape. The report provi...
April 2021
30 pages
Carcinomas (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Carcinomas (Oncology) - Drugs in Development, 2021 SUMMARY Carcinomas (Oncology) - Drugs in Development, 2021 provides an overview of the Carcinomas pipeline landscape. The report provides comprehensi...
April 2021
45 pages
